Search

everythinglearnresearchcommunity

for

Search:↓

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Vertex pattern hair loss linked to higher prostate cancer risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Certain natural compounds called terpenes may help prevent prostate cancer.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Targeting FGF5 could help treat prostate cancer.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

No link was found between hair patterns and prostate cancer risk in South Indian men.

Certain genetic markers may increase or decrease prostate cancer risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.